October 1, 2008—The statement focuses on noninvasive risk stratification for primary prevention of sudden cardiac death and is limited to techniques for ischemic, dilated, and hypertrophic cardiomyopathies.
The statement reports the findings from a writing group convened by the American Heart Association (AHA), the American College of Cardiology Foundation (ACCF), and the Heart Rhythm Society (HRS). The statement focuses on noninvasive risk stratification for primary prevention of sudden cardiac death and is limited to techniques for ischemic, dilated, and hypertrophic cardiomyopathies. The applicability of current noninvasive risk stratification are discussed, organized according to the type of testing required to obtain the information.
Topic
- Clinical Topics
- Sudden Cardiac Arrest
Resource Type
- Clinical Guidelines
Related Resources
Clinical Guidelines
2026 HRS/AHA/APHRS/EHRA/IDSA/LAHRS/PACES/STS Expert Consensus Statement Update on Cardiovascular Implantable Electronic Device Lead Management and Extraction
April 23, 2026
Clinical Guidelines
2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion
August 4, 2025
Clinical Guidelines
2024 HRS Expert Consensus Statement on Arrhythmias in the Athlete: Evaluation, Treatment, and Return to Play
May 17, 2024